Clinical Trial Update: Exparel Injection Effect on Postoperative Opioid Usage [EARLY_Phase 1]

View source ↗

Summary

An early phase 1 trial update examining Exparel (bupivacaine liposome injectable suspension) for its effect on postoperative opioid requirements in thyroid and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parathyroid Adenoma
• Thyroid Disease

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Thyroid, Parathyroid Adenoma | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION